SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001136261-21-000206
Filing Date
2021-09-02
Accepted
2021-09-02 16:03:06
Documents
2
Period of Report
2021-09-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7462
2 exh24.htm EX-24 5660
  Complete submission text file 0001136261-21-000206.txt   14634
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TURTLE CT FLEMINGTON NJ 08822
Business Address
Golembiewski Michael Joseph (Reporting) CIK: 0001639479 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 211233233